http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201536280-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8453f4e92e2d1900eefa4cc3712a585f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
| filingDate | 2014-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c021d2de4af8ff70b375c9a4078284f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2010dae2595ca5ec2c45e759adcf6a28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6636a1b28a339a74cebcac56604d519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ca21f7c3c1607c0158cc39689440557 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c10bb537cbbb4279f4a700103d199f0e |
| publicationDate | 2015-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201536280-A |
| titleOfInvention | Use of Ugonin compound for preparing medicine for treating skin cancer |
| abstract | The present invention relates to a Ugonin compound for use in the preparation of a medicament for treating skin cancer, which is administered an effective dose of Ugonin compound to the skin to promote cell cycle arrest, regulate cell cycle related genes or protein expression, and promote apoptosis. Gene or protein expression, and reduce the ability of cancer cells to migrate and invade; thereby, Ugonin compounds can be further utilized as a pharmaceutical composition for treating skin cancer or slowing the development of skin cancer, thereby effectively inhibiting the growth, migration and invasion of skin cancer cells. efficacy. |
| priorityDate | 2014-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 208.